A mechanism can be interesting without being ready for marketing
It sends a signal to your brain to let you know that you are full and to stop eating
Distinct from prior reviews that predominantly focus on a single drug class or limited clinical indications, this article systematically contrasts the mechanistic pathways, therapeutic efficacy, and safety profiles of GLP-1RAs versus GLP-1/GIP dual receptor agonists
Globally conducted clinical trials have shown that semaglutide can provide superior glycemic control and body weight loss compared with placebo, sitagliptin, exenatide extended-release or insulin glargine [13,14,15,16,17,18,19] and compared with additional oral anti-diabetic drugs investigated in a dedicated Japanese trial [20]
In their paper for Ophthalmology , the study authors explained that their work accomplished two things
However, when something keeps coming back, gets worse, or lasts longer than expected, that's worth noting